|
7 Companies |
|
6 Products |
|
6 Products |
|
10 Mechanisms of Action |
|
0 Trials |
|
70 News |
|
| «12 |
- enoxaparin sodium / Generic mfg.
Enrollment change: PREFIX: Prevention of Unexplained Recurrent Abortion by Enoxaparine (clinicaltrials.gov) - Apr 21, 2014
P3, N=258, Terminated, Sponsor: University Hospital, Brest
N=610 --> 258
- Enrollment change: Pharmacokinetics of Low Molecular Weight and Unfractionated Heparin in Pregnancy (clinicaltrials.gov) - Mar 26, 2014
P=N/A, N=14, Active, not recruiting, Sponsor: University of Chicago
N=610 --> 258 N=30 --> 14
- Clinical: Dilapan-S Osmotic Dilator in Pre-induction of Labor (clinicaltrials.gov) - Mar 26, 2014
P=N/A, N=80, Not yet recruiting, Sponsor: Medicem International CR s.r.o.
- Enrollment closed: Pharmacokinetics of Low Molecular Weight and Unfractionated Heparin in Pregnancy (clinicaltrials.gov) - Mar 26, 2014
P=N/A, N=14, Active, not recruiting, Sponsor: University of Chicago
N=30 --> 14 Recruiting --> Active, not recruiting
- Trial completion: TBA on IVF: Impact of Sperm DNA Integrity on In Vitro Cycles (clinicaltrials.gov) - Mar 13, 2014
P=N/A, N=420, Completed, Sponsor: North Shore Long Island Jewish Health System
Recruiting --> Active, not recruiting Active, not recruiting --> Completed
- ||| Trial completion: Chronic Endometritis in Patients With Recurrent Miscarriages or Repeated Implantation Failures in In-vitro Fertilization (clinicaltrials.gov) - Mar 11, 2014
P=N/A, N=60, Completed, Sponsor: OVO R & D
Active, not recruiting --> Completed Recruiting --> Completed
- | Trial completion: Folic Acid vs 5-methyltetrahydrofolate (5MTHF) in Recurrent Abortion (clinicaltrials.gov) - Nov 5, 2013
P2/3, N=87, Completed, Sponsor: National Nutrition and Food Technology Institute
Recruiting --> Completed Not yet recruiting --> Completed
- || New P2/3 trial: Folic Acid vs 5-methyltetrahydrofolate (5MTHF) in Recurrent Abortion (clinicaltrials.gov) - Nov 4, 2013
P2/3, N=87, Completed, Sponsor: National Nutrition and Food Technology Institute
- enoxaparin sodium / Generic mfg.
Trial termination: PREFIX: Prevention of Unexplained Recurrent Abortion by Enoxaparine (clinicaltrials.gov) - Oct 17, 2013
P3, N=258, Terminated, Sponsor: University Hospital, Brest
Not yet recruiting --> Completed Active, not recruiting --> Terminated; Stopped for futility
- | Privigen (human immune globulin intravenous 10%) / CSL Behring
Enrollment closed: Trial of the Efficacy of Intravenous Immunoglobulin for Treating Women With Unexplained Secondary Recurrent Miscarriage (clinicaltrials.gov) - Sep 15, 2013
P3, N=82, Active, not recruiting, Sponsor: Rigshospitalet, Denmark
Active, not recruiting --> Terminated; Stopped for futility Recruiting --> Active, not recruiting
- Enrollment change: Maternal Lifestyle and Neonatal Hypoglycemia (clinicaltrials.gov) - Apr 21, 2013
P=N/A, N=1000, Enrolling by invitation, Sponsor: Hospital dos Servidores do Estado do Rio de Janeiro
Recruiting --> Active, not recruiting N=200 --> 1000
- | Trial completion: Optimum Misoprostol Dose Prior to Office Hysteroscopy (clinicaltrials.gov) - Apr 9, 2013
P3, N=132, Completed, Sponsor: Cairo University
N=200 --> 1000 Recruiting --> Completed
- || Enrollment change: Accuracy and Reliability of Fetal Heart Rate and Uterine Contraction Monitoring Method (clinicaltrials.gov) - Mar 19, 2013
P=N/A, N=60, Completed, Sponsor: Monica Healthcare Ltd
Recruiting --> Completed N=112 --> 60
- | New P4 trial: Intralipid for Recurrent Miscarriage (clinicaltrials.gov) - Feb 7, 2013
P4, N=300, Recruiting, Sponsor: Woman's Health University Hospital, Egypt
- HEOR, Cost effectiveness: Post Abortion IUD & Recurrent Abortion 2005-2006 (clinicaltrials.gov) - Jan 24, 2013
P=N/A, N=1308, Completed, Sponsor: University of British Columbia
- | progesterone / Generic mfg.
New P4 trial: Pr-conceptional Progesterone for Unexplained Recurrent Miscarriage (clinicaltrials.gov) - Aug 20, 2012
P4, N=400, Recruiting, Sponsor: Woman's Health University Hospital, Egypt
- Enrollment change, HEOR, Cost effectiveness: Post Abortion IUD & Recurrent Abortion 2001-2004 (clinicaltrials.gov) - Jun 26, 2012
P=N/A, N=1101, Completed, Sponsor: University of British Columbia
N=112 --> 60 N=600 --> 1101
- Trial completion, HEOR, Cost effectiveness: Post Abortion IUD & Recurrent Abortion 2001-2004 (clinicaltrials.gov) - Jun 26, 2012
P=N/A, N=1101, Completed, Sponsor: University of British Columbia
N=600 --> 1101 Not yet recruiting --> Completed
- || New P3 trial: Optimum Misoprostol Dose Prior to Office Hysteroscopy (clinicaltrials.gov) - Jun 3, 2012
P3, N=132, Completed, Sponsor: Cairo University
- | enoxaparin sodium / Generic mfg.
New P4 trial: LMWH-APAN: Low Molecular Weight Heparin in Recurrent Miscarriage With Negative Antiphospholipid Antibodies (clinicaltrials.gov) - May 29, 2012
P4, N=228, Active, not recruiting, Sponsor: Omar Mamdouh Shaaban